Eptinezumab in Adults With Migraine and Medication Overuse Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

May 23, 2022

Study Completion Date

September 30, 2022

Conditions
MigraineMedication Overuse Headache
Interventions
DRUG

Placebo

Placebo - solution for infusion

DRUG

Eptinezumab

Eptinezumab - 100 mg, solution for infusion

Trial Locations (40)

8035

Hospital Universitario Vall d'Hebron - PPDS, Barcelona

11217

Taipei Veterans General Hospital, Taipei

11490

Tri-Service General Hospital, Taipei

28046

Hospital Universitario La Paz - PPDS, Madrid

28222

Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda

33305

Chang Gung Memorial Hospital, Linkou, Taoyuan

46010

Hospital Clinico Universitario de Valencia, Valencia

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

50009

Hospital Clinico Universitario Lozano Blesa, Zaragoza

100020

Beijing Chaoyang Hospital Capital Medical University, Beijing

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

100034

Peking University First Hospital, Beijing

100053

Xuanwu Hospital Capital Medical University, Beijing

100730

Peking Union Medical College Hospital, Beijing

100853

Chinese PLA General Hospital, Beijing

110004

Shengjing Hospital of China Medical University, Shenyang

110015

General Hospital of Northern Theater Command, Shenyang

130021

The First Hospital of Jilin University, Changchun

130022

The Second Hospital of Jilin University, Changchun

212001

Affiliated Hospital of Jiangsu University, Zhenjiang

276826

People's Hospital of Rizhao, Rizhao

325035

The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou

337055

Jiangxi Pingxiang People's Hospital, Pingxiang

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

430022

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

430060

Renmin Hospital of Wuhan University, Wuhan

450003

People's Hospital of Zhengzhou, Zhengzhou

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510120

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

518053

The University of Hong Kong - Shenzhen Hospital, Shenzhen

550000

The Affiliated Hospital of Guizhou Medical University, Guiyang

610041

Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University), Beijing

621000

Mianyang Central Hospital, Mianyang

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

030012

Shanxi Provincial People Hospital, Taiyuan

0114

Pineo Medical Ecosystem, Tbilisi

0160

Aversi Clinic LTD, Tbilisi

01830

Nowon Eulji Medical Center, Eulji University, Seoul

03722

Severance Hospital Yonsei University Health System - PPDS, Seoul

06351

Samsung Medical Center - PPDS, Seoul

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04772742 - Eptinezumab in Adults With Migraine and Medication Overuse Headache | Biotech Hunter | Biotech Hunter